Study protocol to investigate biomolecular muscle profile as predictors of long-term urinary incontinence in women with gestational diabetes mellitus.
Adult
Brazil
Cesarean Section
Cohort Studies
Diabetes, Gestational
/ physiopathology
Female
Gestational Age
Gestational Weight Gain
Humans
Maternal Age
Muscle Contraction
/ physiology
Muscle Strength
/ physiology
Muscular Diseases
/ physiopathology
Palpation
Pelvic Floor
/ physiopathology
Postpartum Period
Pregnancy
Rectus Abdominis
/ physiopathology
Urinary Incontinence
/ physiopathology
Vagina
Collagen
Electromyography
Gestational diabetes mellitus
Hyperglycemic myopathy
Pelvic floor muscles
Proteomics
Rectus abdominis muscles
Transmission electron microscopy
Urinary incontinence
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
19 Feb 2020
19 Feb 2020
Historique:
received:
26
10
2019
accepted:
17
01
2020
entrez:
21
2
2020
pubmed:
23
2
2020
medline:
2
12
2020
Statut:
epublish
Résumé
Pelvic floor muscles (PFM) and rectus abdominis muscles (RAM) of pregnant diabetic rats exhibit atrophy, co-localization of fast and slow fibers and an increased collagen type I/III ratio. However, the role of similar PFM or RAM hyperglycemic-related myopathy in women with gestational diabetes mellitus (GDM) remains poorly investigated. This study aims to assess the frequency of pelvic floor muscle disorders and pregnancy-specific urinary incontinence (PS-UI) 12 months after the Cesarean (C) section in women with GDM. Specifically, differences in PFM/RAM hyperglycemic myopathy will be evaluated. The Diamater is an ongoing cohort study of four groups of 59 pregnant women each from the Perinatal Diabetes Research Centre (PDRC), Botucatu Medical School (FMB)-UNESP (São Paulo State University), Brazil. Diagnosis of GDM and PS-UI will be made at 24-26 weeks, with a follow-up at 34-38 weeks of gestation. Inclusion in the study will occur at the time of C-section, and patients will be followed at 24-48 h, 6 weeks and 6 and 12 months postpartum. Study groups will be classified as (1) GDM plus PS-UI; (2) GDM without PS-UI; (3) Non-GDM plus PS-UI; and (4) Non-GDM without PS-UI. We will analyze relationships between GDM, PS-UI and hyperglycemic myopathy at 12 months after C-section. The mediator variables to be evaluated include digital palpation, vaginal squeeze pressure, 3D pelvic floor ultrasound, and 3D RAM ultrasound. RAM samples obtained during C-section will be analyzed for ex-vivo contractility, morphological, molecular and OMICS profiles to further characterize the hyperglycemic myopathy. Additional variables to be evaluated include maternal age, socioeconomic status, educational level, ethnicity, body mass index, weight gain during pregnancy, quality of glycemic control and insulin therapy. To our knowledge, this will be the first study to provide data on the prevalence of PS-UI and RAM and PFM physical and biomolecular muscle profiles after C-section in mothers with GDM. The longitudinal design allows for the assessment of cause-effect relationships between GDM, PS-UI, and PFMs and RAMs myopathy. The findings may reveal previously undetermined consequences of GDM.
Sections du résumé
BACKGROUND
BACKGROUND
Pelvic floor muscles (PFM) and rectus abdominis muscles (RAM) of pregnant diabetic rats exhibit atrophy, co-localization of fast and slow fibers and an increased collagen type I/III ratio. However, the role of similar PFM or RAM hyperglycemic-related myopathy in women with gestational diabetes mellitus (GDM) remains poorly investigated. This study aims to assess the frequency of pelvic floor muscle disorders and pregnancy-specific urinary incontinence (PS-UI) 12 months after the Cesarean (C) section in women with GDM. Specifically, differences in PFM/RAM hyperglycemic myopathy will be evaluated.
METHODS
METHODS
The Diamater is an ongoing cohort study of four groups of 59 pregnant women each from the Perinatal Diabetes Research Centre (PDRC), Botucatu Medical School (FMB)-UNESP (São Paulo State University), Brazil. Diagnosis of GDM and PS-UI will be made at 24-26 weeks, with a follow-up at 34-38 weeks of gestation. Inclusion in the study will occur at the time of C-section, and patients will be followed at 24-48 h, 6 weeks and 6 and 12 months postpartum. Study groups will be classified as (1) GDM plus PS-UI; (2) GDM without PS-UI; (3) Non-GDM plus PS-UI; and (4) Non-GDM without PS-UI. We will analyze relationships between GDM, PS-UI and hyperglycemic myopathy at 12 months after C-section. The mediator variables to be evaluated include digital palpation, vaginal squeeze pressure, 3D pelvic floor ultrasound, and 3D RAM ultrasound. RAM samples obtained during C-section will be analyzed for ex-vivo contractility, morphological, molecular and OMICS profiles to further characterize the hyperglycemic myopathy. Additional variables to be evaluated include maternal age, socioeconomic status, educational level, ethnicity, body mass index, weight gain during pregnancy, quality of glycemic control and insulin therapy.
DISCUSSION
CONCLUSIONS
To our knowledge, this will be the first study to provide data on the prevalence of PS-UI and RAM and PFM physical and biomolecular muscle profiles after C-section in mothers with GDM. The longitudinal design allows for the assessment of cause-effect relationships between GDM, PS-UI, and PFMs and RAMs myopathy. The findings may reveal previously undetermined consequences of GDM.
Identifiants
pubmed: 32075598
doi: 10.1186/s12884-020-2749-x
pii: 10.1186/s12884-020-2749-x
pmc: PMC7031907
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
117Références
Diabetol Metab Syndr. 2010 Apr 23;2(1):26
pubmed: 20416073
Rev Bras Ginecol Obstet. 2011 Apr;33(4):182-7
pubmed: 21845350
J Diabetes Res. 2013;2013:473575
pubmed: 23878822
Rev Med Inst Mex Seguro Soc. 2016 Jan-Feb;54(1):70-4
pubmed: 26820202
Rev Med Chil. 1997 Dec;125(12):1429-36
pubmed: 9609018
Clinics (Sao Paulo). 2011;66(8):1341-6
pubmed: 21915481
Eur J Obstet Gynecol Reprod Biol. 2016 Feb;197:59-62
pubmed: 26706923
Chemometr Intell Lab Syst. 2015 Aug;146:42-46
pubmed: 26052171
Neurourol Urodyn. 2017 Mar;36(3):574-579
pubmed: 26949929
Acta Physiol (Oxf). 2008 Mar;192(3):381-95
pubmed: 17892520
Cell Stress Chaperones. 2013 Jan;18(1):25-33
pubmed: 22821472
Am J Psychiatry. 2016 Jul 1;173(7):672-9
pubmed: 26988629
BJOG. 2012 Oct;119(11):1334-43
pubmed: 22901044
BJU Int. 2000 Feb;85(3):350-61
pubmed: 10671896
Diabetes Res Clin Pract. 2014 Feb;103(2):137-49
pubmed: 24630390
Diabet Med. 2016 Nov;33(11):1528-1535
pubmed: 27028025
J Urol. 2011 Nov;186(5):1768-72
pubmed: 21944102
Mol Cell Biochem. 2012 May;364(1-2):329-35
pubmed: 22307744
Am J Obstet Gynecol. 2016 Aug;215(2):210.e1-7
pubmed: 26875952
Neurourol Urodyn. 2012 Jan;31(1):190-4
pubmed: 22038896
Arch Gen Psychiatry. 2002 Oct;59(10):877-83
pubmed: 12365874
Eur J Obstet Gynecol Reprod Biol. 2014 Jul;178:27-34
pubmed: 24784708
Neurourol Urodyn. 2011 Jan;30(1):117-20
pubmed: 21046655
Front Physiol. 2015 Aug 14;6:231
pubmed: 26321962
Biochim Biophys Acta Mol Basis Dis. 2020 Feb 1;1866(2):165478
pubmed: 31152867
PLoS One. 2014 Sep 12;9(9):e106872
pubmed: 25216282
Arch Intern Med. 2005 Mar 14;165(5):537-42
pubmed: 15767530
J Womens Health (Larchmt). 2008 Jun;17(5):783-92
pubmed: 18537481
Braz J Med Biol Res. 2018 Mar 01;51(4):e7035
pubmed: 29513796
Am J Obstet Gynecol. 2008 Dec;199(6):610.e1-5
pubmed: 18533115
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
Ultrasound Obstet Gynecol. 2005 Jun;25(6):580-5
pubmed: 15883982
Ultrasound Obstet Gynecol. 2014 Oct;44(4):476-80
pubmed: 24436146
Diabetes. 2010 Jan;59(1):33-42
pubmed: 19833877
Free Radic Biol Med. 2008 Feb 15;44(4):584-93
pubmed: 18053817
Early Interv Psychiatry. 2010 May;4(2):143-52
pubmed: 20536970
Diabetol Metab Syndr. 2009 Oct 19;1(1):21
pubmed: 19840387
Am J Physiol Regul Integr Comp Physiol. 2006 Sep;291(3):R837-43
pubmed: 16513765
BMJ Open. 2018 Feb 22;8(2):e018792
pubmed: 29472262
Neurourol Urodyn. 2008;27(5):429-34
pubmed: 18351620
Digestion. 2004;69(2):93-101
pubmed: 15087576
BMC Pregnancy Childbirth. 2013 Jun 21;13:133
pubmed: 23800121
Neurourol Urodyn. 2006;25(7):722-30
pubmed: 16817184
Rev Saude Publica. 2004 Jun;38(3):438-44
pubmed: 15243675
Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(5):278-83
pubmed: 12355285
Biomed Res Int. 2014;2014:676758
pubmed: 25197655
Diabetes Care. 2005 May;28(5):1035-40
pubmed: 15855563
Diabetes Res Clin Pract. 2015 Dec;110(3):309-14
pubmed: 26489823
Man Ther. 2004 Feb;9(1):3-12
pubmed: 14723856
Urology. 2003 Jan;61(1):37-49
pubmed: 12559262
Int Urogynecol J. 2010 Jun;21(6):637-43
pubmed: 20135305
Am J Obstet Gynecol. 2015 Aug;213(2):191.e1-7
pubmed: 25979618
Int Urogynecol J. 2014 Mar;25(3):403-15
pubmed: 24043129
Neurourol Urodyn. 2005;24(4):374-80
pubmed: 15977259
J Orthop Sports Phys Ther. 2009 Aug;39(8):604-611
pubmed: 19648721
Muscle Nerve. 2006 Sep;34(3):320-6
pubmed: 16775833
Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:81-88
pubmed: 29275277
Am J Obstet Gynecol. 2003 Jun;188(6):S77-88
pubmed: 12825024
Biomed Res Int. 2014;2014:819065
pubmed: 24977161
J Orthop Sports Phys Ther. 2011 Jun;41(6):435-43
pubmed: 21289454